Delivery Order SPE2DB25D2204-SPE2DB25FTGPY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency awarded a $6,978.90 delivery order to AmerisourceBergen Drug Corp for Latuda 40 mg tablets (30-count units) on September 18, 2025, with a completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count) with a ceiling value of $5,207.81. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 26, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Latuda 60 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,418.64 and an ultimate completion date of September 11, 2025. The contract was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $4,686.35 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 40 mg tablets of LATUDA. The delivery order, issued under DLA's Prime Vendor program, calls for Amerisourcebergen to deliver 30 tablets of LATUDA to a location in Conshohocken, Pennsylvania by July 10, 2023. As the prime contractor, Amerisourcebergen will be responsible for fulfilling the order without the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Latuda 60 mg, a medication used to treat bipolar disorder and schizophrenia, valued at $3,040.56. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by August 25, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency Troop Support Medical awarded a $5,454.48 firm fixed price delivery order to Amerisourcebergen Drug Corporation for LATUDA 80 MG tablets. Under the contract, Amerisourcebergen will deliver 30 tablets of LATUDA to a location in Conshohocken, Pennsylvania. The delivery order was awarded on July 14, 2023 and concludes on July 17, 2023. No major subcontractors or set aside designations were specified. The Defense Logistics Agency supports the Department of Defense by...
- The Defense Logistics Agency awarded a $163,360 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 packages of 20mg Latuda tablets. The order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 28, 2023 in support of the Defense Logistics Agency's pharmaceutical procurement programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceutical supply vehicle to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,563.00, is for the provision of Latuda 20 mg tablets to support military and federal healthcare programs. The contract has an ultimate completion date of December 23, 2024 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGPYDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $28,377.71 by the Defense Logistics Agency to supply Latuda 20 mg tablets (30-count packages). This firm fixed price, competitively awarded contract was issued on June 9, 2025, with an ultimate completion date of June 10, 2025. The pharmaceutical products will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to supply a wide range of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Latuda, an atypical antipsychotic medication used primarily in psychiatric care, aligns with the company's established role as a comprehensive medical supply provider for federal healthcare programs. This non-set-aside award reflects the company's competitive standing in federal pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 6/9/25 |